| Lendue drops*os fl gtt 12g • liki24.co.uk | 16.90 RON |
| Lendue gotas*os fl gtt 12g • liki24.es | 20.20 RON |
| Lendue Tropfen*os fl gtt 12g • liki24.at | 20.20 RON |
NAME LENDUE DROPS 120 MG/G ORAL SUSPENSION FOR DOGS AND CATS ACTIVE INGREDIENTS 100 g of suspension contain: active ingredient: micronized mebendazole 12 g. For a full list of excipients, see * 6.1. EXCIPIENTS White petrolatum, olive oil. THERAPEUTIC INDICATIONS Parasitic infections caused by: Ancylostoma caninum, Ancylostoma braziliense, Uncinaria stenocephala, Toxocara canis, Toxascaris leonina, Toxocara cati, Trichuris vulpis, Strongyloides stercoralis, Taenia spp. CONTRAINDICATIONS / ADVERSE EFFECTS None. SAFETY IN TARGET SPECIES Administration of excessive doses does not cause any symptoms other than vomiting above 500 mg/kg of active ingredient in dogs and 300 mg/kg of active ingredient in cats. DOSAGE For oral administration. One drop of suspension contains 3.75 mg of active substance. Administer 8 drops per kg of body weight of the animal per day (equivalent to 30 mg/kg body weight/day of Mebendazole): for two consecutive days, in infestations caused by Ancylostoma caninum, Ancylostoma braziliense, Uncinaria stenocephala, Toxocara canis, Toxascaris leonina, Toxocara cati, Trichuris vulpis, Strongyloides stercoralis, Taenia spp., both single and mixed; for one day only, in infestations caused only by the hematopoietic worms Ancylostoma caninum, Ancylostoma braziliense, Uncinaria stenocephala. Lendue drops can be administered to puppies even in the first weeks of life without any problems. Always round the weight of the animal up to the next whole number. The drops are palatable to the animals; can be administered directly into the mouth or incorporated into palatable food. Shake vigorously before use until the sediment is completely dispersed. Administration of Lendue drops according to the instructions will completely eliminate adult parasites; to eliminate larval forms, repeat the complete treatment 60 days after the end of the first treatment for Ascaris infestations and 18 days after the end of the first treatment for hookworm infestations. STORAGE: Store at room temperature. Keep the bottle tightly closed. Keep out of the reach of children. Shelf life of the veterinary medicinal product as packaged for sale: 4 years. WARNINGS: In order to obtain effective parasite control, treatment should be carried out based on the results of the fecal parasitological examination. It is not necessary to fast during treatment; however, it is good practice during deworming and starting the day before to feed the animal smaller and lighter meals than usual. It is preferable to administer the product on an empty stomach. The elimination of parasites begins after the first administration and the eggs usually disappear within 10-15 days of the last administration. Therefore, faecal examinations should be carried out after this period of time has elapsed. During and after treatment, appropriate disinfection procedures should be carried out, especially in kennels or breeding units, to prevent reinfestation. In addition, it is recommended to chemically denature the faeces expelled by the treated subjects in order to destroy any live parasites eliminated and thus interrupt the continuation of the parasitic cycle. Special precautions for use in animals: None. Special precautions to be taken by the person administering the product to animals: None. The administration of excessive doses does not cause symptoms other than vomiting. Doses exceeding 500 mg/kg of active ingredient in dogs and 300 mg/kg of active ingredient in cats do not cause any symptoms. In the absence of compatibility studies, do not mix with other medicinal products. TARGET SPECIES: Dogs and cats. INTERACTIONS: None known. DIAGNOSIS AND PRESCRIPTION: Veterinary medicinal product available without a prescription. ADVERSE REACTIONS: Report any serious adverse reactions and/or reactions not mentioned in this SPC. PREGNANCY AND LACTATION: Do not administer Lendue drops during the first fifteen days of pregnancy. In the absence of studies on the target species, administer during the remaining 45 days of pregnancy and during lactation only according to the risk/benefit assessment carried out by the responsible veterinarian